Print

India will strengthen global health efforts: PM Modi to WHO chief

India will work towards efforts to boost global health, said Prime Minister Narendra Modi on Tuesday while pledging his support to World Health Organisation chief Dr. Tedros Adhanom Ghebreyesus, who he addresses as ‘Tulsi Bhai’.

He said this in response to Ghebreyesus’ post on X, thanking PM Modi and others for their support and contributions during the first-ever WHO Investment Round held in Brazil.

The Prime Minister said that India is actively working in the health sector by integrating technology.

“Dear Tulsi Bhai, A healthy planet is a better planet. India is working actively in this sector,” PM Modi said in the post on X.

“We are attaching great priority to integrating technology too. At the same time, we will strengthen global efforts in this regard,” he added.

The WHO organised its first-ever Investment Round to raise funds for its strategy for global health during the G20 Leaders’ Summit in Brazil’s Rio de Janeiro.

The event, attended by world leaders along with Prime Minister Modi, “raised $ 1.7 billion”.

At the Summit, the leaders reaffirmed their commitment to building a fair world and a sustainable planet. They pledged to prioritise the fight against inequalities in all their dimensions.

Their declaration reaffirmed the WHO’s central role in global health governance, emphasising the need for stable and transparent financing.

They also backed the WHO Investment Round as a means to secure additional funding for the organisation’s activities.

“Investment in @WHO is an investment in global health security,” the WHO chief posted on X.

The global health body said that it “has $ 3.8 billion toward its $ 7.1 billion goal”.

This also marks “a 53% funding for the 14th General Programme of Work — set to save 40 million additional lives over the next 4 years”, the UN agency said.

(Inputs from IANS)

RELATED ARTICLES

09/06/26 | 3:12 pm | GLP-1 drugs

Use of GLP-1 drugs early in pregnancy should not cause alarm, analysis suggests

Use of GLP-1 drugs for diabetes or obesity early in the first trimester of pregnancy, before a woman realizes she is pregnant, is not a cause for alarm, a large new data analysis suggests. These medications, which include Novo Nordisk’s semaglutid...

09/06/26 | 1:47 pm | ICMR-National Institute of Nutrition (ICMR-NIN)

ICMR-NIN study links micronutrient deficiencies to higher dementia

A study conducted by the ICMR-National Institute of Nutrition (ICMR-NIN) has found a significant association between micronutrient deficiencies and a higher risk of dementia among Indian adults, highlighting the potential role of nutrition in prevent...

09/06/26 | 10:55 am | GDRC (Global Drug Regulators Conclave) 2026

Piyush Goyal invites global pharma firms to invest in India

Union Commerce and Industry Minister Piyush Goyal on Monday invited global pharmaceutical companies to partner with India as it advances towards innovation-led and inclusive healthcare, saying the country's pharmaceutical industry, currently valued a...